Lin Pi
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The impact of primary percutaneous coronary intervention timing on prognosis in STEMI patients.
Journal: Clinical medicine (London, England)
Published: March 20, 2026
No association between low-dose reserpine use and depression in older hypertensive patient: result of a multicenter, cross-sectional study.
Journal: Journal of geriatric cardiology : JGC
Published: September 27, 2019
Mesenchymal Stem Cell Therapy for Patients with Ischemic Heart Failure- Past, Present, and Future.
Journal: Current stem cell research & therapy
Published: August 29, 2019
Chinese expert consensus on the management of hypertension in the very elderly.
Journal: Journal of geriatric cardiology : JGC
Published: January 01, 2016
Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Multicenter Clinical Trial in China.
Journal: Current therapeutic research, clinical and experimental
Published: October 09, 2015
Impact of therapy options on in-hospital and three-year outcome of patients with ST-elevation myocardial infarction in Beijing.
Journal: Zhonghua xin xue guan bing za zhi
Published: October 23, 2013
Control rate of increased low-density lipoprotein cholesterol levels in cardiology outpatients with coronary heart disease in Beijing
Journal: Zhonghua xin xue guan bing za zhi
Published: July 25, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026